Search

Your search keyword '"LUISA GUIDI"' showing total 55 results
Start Over Author "LUISA GUIDI" Journal digestive and liver disease
55 results on '"LUISA GUIDI"'

2. OC.02.5 EFFECTIVENESS, SAFETY AND IMMUNOGENICITY OF SWITCHING FROM ORIGINATOR INFILIXIMAB TO BIOSIMILAR INFLIXIMAB (CT-P13) IN A LARGE COHORT OF IBD PATIENTS

Author

A. Papa, Luigi Giovanni Papparella, Elisa Gremese, A. Armuzzi, Daniela Pugliese, G.L. Rapaccini, Giuseppe Privitera, B. Tolusso, Alessandro Gasbarrini, and Luisa Guidi

Subjects
medicine.medical_specialty, Hepatology, business.industry, Internal medicine, Immunogenicity, Gastroenterology, medicine, Biosimilar, business, Infliximab, medicine.drug, Large cohort
Published
2020
Full Text
View/download PDF

3. T04.01.16 VALIDITY AND APPLICABILITY OF HOSPITAL ANXIETY AND DEPRESSIONE SCALE (HADS) AND DISTRESS THERMOMETER (TD) IN INFLAMMATORY BOWEL DISEASES: AN ITALIAN MULTICENTER STUDY

Author

P. Cai, C. Canaletti, G.M. Pecoraro, Daniela Pugliese, C. Tonello, M. Piacentino, A. Tongiorgi, E. Geccherle, A. Geccherle, Fabrizio Bossa, F. Giudici, F. Colombo, F.M. Onidi, Luisa Guidi, M.G. Motillaro, Fabio Monica, Giammarco Mocci, Francesco Costa, A. Dessi, L. Tiberio, G. Deldda, and A. Orlando

Subjects
Hospital anxiety, medicine.medical_specialty, Hepatology, Scale (ratio), Multicenter study, business.industry, Gastroenterology, Physical therapy, medicine, Inflammatory Bowel Diseases, Distress Thermometer, business
Published
2020
Full Text
View/download PDF

4. OC.09.6 PERFORATING CROHN'S DISEASE AND EXTENSIVE COLITIS AS RISK FACTORS FOR INCIDENT CANCER: A MULTICENTER NESTED CASE-CONTROL IG-IBD STUDY AT 6 YEARS

Author

Luisa Spina, A. Rossi, Renata D'Incà, Stefano Festa, A. Armuzzi, Marco Daperno, Maurizio Vecchi, Luisa Guidi, E. De Cristofaro, Livia Biancone, A. Orlando, R. Di Mitri, M. Patturelli, Gianmichele Meucci, Sara Renna, Fabiana Castiglione, Francesca Rogai, Emma Calabrese, B. Neri, Gabriele Riegler, Claudio Papi, Walter Fries, P. Alvisi, Anna Testa, C. Gesuale, Carmelina Petruzziello, F. Mocciaro, and Maria Lia Scribano

Subjects
medicine.medical_specialty, Crohn's disease, Hepatology, business.industry, Internal medicine, Nested case-control study, Gastroenterology, medicine, Cancer, Colitis, medicine.disease, business
Published
2019
Full Text
View/download PDF

5. OC.12.3 INCIDENT CANCER IN INFLAMMATORY BOWEL DISEASE IN A PROSPECTIVE MULTICENTER NESTED CASE-CONTROL IG-IBD STUDY

Author

Marco Daperno, A. Armuzzi, Stefano Festa, Maurizio Vecchi, A. Rossi, Renata D'Incà, A. Orlando, S. Romeo, A. Ruffa, Livia Biancone, F. Mocciaro, Maria Lia Scribano, Luisa Guidi, R. Di Mitri, Gianmichele Meucci, Sara Renna, Walter Fries, Francesco Pallone, Emma Calabrese, Francesca Rogai, Carmelina Petruzziello, Claudio Papi, P. Alvisi, Luisa Spina, Fabiana Castiglione, Sandro Ardizzone, B. Neri, and Gabriele Riegler

Subjects
medicine.medical_specialty, Hepatology, business.industry, Internal medicine, Nested case-control study, Gastroenterology, medicine, Cancer, medicine.disease, business, Inflammatory bowel disease
Published
2018
Full Text
View/download PDF

6. OC.12.5 VEDOLIZUMAB TROUGH LEVELS AND CLINICAL OUTCOMES IN INFLAMMATORY BOWEL DISEASE

Author

Daniela Pugliese, A. Armuzzi, B. Tolusso, C. Di Mario, A. Papa, G.L. Rapaccini, S. Ennas, T. Panici Tonucci, C. Felice, Alessandro Gasbarrini, and Luisa Guidi

Subjects
medicine.medical_specialty, Hepatology, business.industry, Internal medicine, Gastroenterology, Trough (geology), medicine, medicine.disease, business, Inflammatory bowel disease, Vedolizumab, medicine.drug
Published
2018
Full Text
View/download PDF

7. P092 Observational study on transition care for young adults with inflammatory bowel disease: results and perspectives

Author

B. Papadatou, Alessandro Gasbarrini, Luisa Guidi, Franca Viola, M. Aloi, Salvatore Cucchiara, F. Bracci, Daniela Knafelz, Daniela Pugliese, A. Armuzzi, and Antonio Corsello

Subjects
Transition Care, Pediatrics, medicine.medical_specialty, Hepatology, business.industry, Gastroenterology, medicine, Observational study, Young adult, business, medicine.disease, Inflammatory bowel disease
Published
2018
Full Text
View/download PDF

8. Interleukin-6 release in the hepatic blood outflow during normothermic liver ischaemia in humans

Author

A.R. Errani, A. Tricerri, Daniela Frasca, E Adducci, Paola Barattini, Giovanni Gasbarrini, G. De Cosmo, Gennaro Nuzzo, Luisa Guidi, M. Costanzo, Carlo Bartoloni, and M. Ciarniello

Subjects
Adult, Male, medicine.medical_specialty, Pathology, medicine.medical_treatment, Ischemia, Hemodynamics, Gastroenterology, Proinflammatory cytokine, Interferon-gamma, Internal medicine, medicine, Hepatectomy, Humans, Vein, Aged, Porta hepatis, Hepatology, medicine.diagnostic_test, Interleukin-6, Tumor Necrosis Factor-alpha, business.industry, Middle Aged, medicine.disease, Cytokine, medicine.anatomical_structure, Liver, Female, Liver function tests, business, Interleukin-1
Abstract

Background. Liver surgery techniques have consistently improved and normothermic ischaemia of the liver is considered to be a safe procedure to reduce intraoperative haemorrhage. Hepatic failure, however, remains a significant complication. In liver ischaemia–reperfusion injury, cytokines play a key proinflammatory role. Cytokines may be part of the intercellular signalling that leads to recovery or to failure after major surgery. Moreover, they could be potential predictors of the outcome. Modulation of the pattern of cytokine response in the early postsurgery period could represent a new approach to minimise the impact of these procedures. Aims. The aim of our study was to analyse the cytokine pattern in the hepatic blood outflow in patients undergoing surgical intervention of partial liver resection with clamping of the hepatic pedicle and liver ischaemia, and to correlate the cytokine behaviour with clinical parameters. Patients. We studied eight patients (mean age 55 years) who underwent surgical intervention of liver resection during vascular exclusion of the hepatic pedicle. Patients were monitored for haemodynamic and haematological parameters during the pre-, infra- and postoperative period. Methods. IL-1 α, IL-6, TNF-α and IFN-γ were assayed from peripheral and central vein blood at different times. Blood samples for cytokine assays were also drawn from the supra-hepatic veins after clamping of the porta hepatis. Results. We found a significant increase of the IL-6 levels in the supra-hepatic samples during liver ischaemia, while the trend with IL-1α was less clear; IFN-γ and TNF-α were undetectable with the methods used. IL-6 levels appeared to correlate positively with bilirubin and γ-GT levels and negatively with the degree of acidosis. Conclusions. Our study confirms that during surgical ischaemic stress there is an increase of IL-6 serum levels more relevant in supra-hepatic vein blood. Cytokines could contribute to modulate the inflammatory response to liver ischaemia.

Published
2003
Full Text
View/download PDF

11. P.11.4: Mucosal Healing with a Second Anti-Tnf in Patients with Ulcerative Colitis After the Failure of the Previous Anti-Tnf Treatment

Author

Rosario Landi, I. De Vitis, A. Armuzzi, Daniela Pugliese, Luisa Guidi, C. Felice, A. Papa, G.L. Rapaccini, and F. D'Aversa

Subjects
medicine.medical_specialty, Hepatology, business.industry, Internal medicine, Mucosal healing, Gastroenterology, medicine, In patient, Tumor necrosis factor alpha, medicine.disease, business, Ulcerative colitis
Published
2017
Full Text
View/download PDF

12. OC.06.6: Therapeutic Drug Monitoring of Infliximab for the Management of Loss of Response in Inflammatory Bowel Disease: An Observational Multicenter Study

Author

Fortunata Civitelli, A. Armuzzi, Lorenzo Bertani, T. Panici Tonucci, Francesco Costa, G.L. Rapaccini, Anna Kohn, Laura Cantoro, Michele Cicala, Franca Viola, Paola Balestrieri, B. Tolusso, Daniela Pugliese, and Luisa Guidi

Subjects
medicine.medical_specialty, Hepatology, medicine.diagnostic_test, business.industry, Gastroenterology, medicine.disease, Inflammatory bowel disease, Infliximab, Multicenter study, Therapeutic drug monitoring, Internal medicine, medicine, Observational study, business, medicine.drug
Published
2017
Full Text
View/download PDF

13. OC.11.1 INFLAMMATORY BOWEL DISEASE PHENOTYPE AS RISK FACTOR FOR CANCER IN A PROSPECTIVE MULTICENTER NESTED CASE-CONTROL IG-IBD STUDY

Author

Francesca Rogai, Luisa Guidi, Walter Fries, A. Armuzzi, Maurizio Vecchi, G. Meucci, Francesco Pallone, Emma Calabrese, F. Mocciaro, Anna Kohn, Maria Lia Scribano, A. Rossi, Renata D'Incà, Carmelina Petruzziello, Sara Renna, E. Angelucci, A. Ruffa, A. Orlando, Luisa Spina, L. Biancone, Sandro Ardizzone, R. Di Mitri, Fabiana Castiglione, Gabriele Riegler, Claudio Papi, P. Alvisi, and Marco Daperno

Subjects
Oncology, medicine.medical_specialty, Hepatology, business.industry, Gastroenterology, Cancer, medicine.disease, Inflammatory bowel disease, Phenotype, Internal medicine, Nested case-control study, medicine, Risk factor, business
Published
2016
Full Text
View/download PDF

14. P.16.1 INFLIXIMAB AND TNF ALFA MEASUREMENT IN INTESTINAL MUCOSA OF IBD PATIENTS: A NEW TOOL FOR THE CLINIC?

Author

Alessandro Sgambato, A. Papa, Franco Scaldaferri, Andrea Poscia, Valentina Petito, Silvia Pecere, Mariachiara Campanale, Alessandro Gasbarrini, Luisa Guidi, A. Armuzzi, Giovanni Cammarota, G.L. Rapaccini, and A. Amato

Subjects
medicine.medical_specialty, Hepatology, Intestinal mucosa, business.industry, Internal medicine, Gastroenterology, Medicine, Tumor necrosis factor alpha, business, Infliximab, medicine.drug
Published
2012
Full Text
View/download PDF

15. P.05.5 PREDICTIVE FACTORS OF ONE-YEAR MUCOSAL HEALING IN A COHORT OF ULCERATIVE COLITIS PATIENTS TREATED WITH INFLIXIMAB

Author

C. Felice, I. De Vitis, Manuela Marzo, A. Armuzzi, Alessandro Gasbarrini, Luisa Guidi, G.L. Rapaccini, A. Papa, Giammarco Mocci, Gianluca Andrisani, and Daniela Pugliese

Subjects
medicine.medical_specialty, Hepatology, business.industry, Gastroenterology, medicine.disease, Ulcerative colitis, Infliximab, Internal medicine, Mucosal healing, Cohort, medicine, business, medicine.drug
Published
2012
Full Text
View/download PDF

16. P.1.76: PREVALENCE AND NATURAL HISTORY OF HEPATITIS B AND C VIRUS INFECTION IN A LARGE COHORT OF PATIENTS AFFECTED BY INFLAMMATORY BOWEL DISEASE IN TREATMENT WITH ANTI-TNF-A AGENTS

Author

A. Armuzzi, Daniela Pugliese, Manuela Marzo, A. Papa, G.L. Rapaccini, C. Felice, Giammarco Mocci, I. De Vitis, Marcello Covino, Franco Scaldaferri, Gianluca Andrisani, Alessandro Gasbarrini, and Luisa Guidi

Subjects
medicine.medical_specialty, Hepatology, business.industry, Gastroenterology, Hepatitis B, medicine.disease, Inflammatory bowel disease, Virus, Large cohort, Natural history, Internal medicine, Immunology, medicine, Tumor necrosis factor alpha, business
Published
2011
Full Text
View/download PDF

17. P.98 PREDICTIVE AND PROTECTIVE FACTORS OF FUTURE COLECTOMY IN PATIENTS WITH EXTENSIVE ULCERATIVE COLITIS: A PROSPECTIVE LONG-TERM STUDY

Author

A. Papa, A. Armuzzi, Franco Scaldaferri, Manuela Marzo, Giammarco Mocci, Alessandro Gasbarrini, Luisa Guidi, I. De Vitis, Gianluca Andrisani, and C. Felice

Subjects
medicine.medical_specialty, Hepatology, business.industry, medicine.medical_treatment, General surgery, Gastroenterology, medicine.disease, Ulcerative colitis, Long term learning, Internal medicine, medicine, In patient, business, Colectomy
Published
2010
Full Text
View/download PDF

18. P.86 PREVALENCE AND NATURAL HISTORY OF HEPATITIS B AND C INFECTION IN A POPULATION OF IBD PATIENTS TREATED WITH ANTI-TUMOR NECROSIS FACTOR-α AGENTS

Author

Franco Scaldaferri, G. Vitale, A. Papa, Daniela Pugliese, Manuela Marzo, C. Felice, I. De Vitis, A. Armuzzi, Gianluca Andrisani, Giammarco Mocci, G.L. Rapaccini, Alessandro Gasbarrini, Luisa Guidi, and L. Sparano

Subjects
education.field_of_study, Hepatology, business.industry, Population, Gastroenterology, Hepatitis B, medicine.disease, Virology, Natural history, Anti tumor necrosis factor α, Immunology, medicine, education, business
Published
2010
Full Text
View/download PDF

19. P.228 TUBERCOLOSIS SCREENING IN ITALIAN PATIENTS AFFECTED BY INFLAMMATORY BOWEL DISEASE: COMPARISON OF QUANTIFERON-TB GOLD VERSUS TUBERCULIN SKIN TEST

Author

I. De Vitis, Giovanni Delogu, C. Felice, A. Ruggeri, Manuela Marzo, A. Papa, Fausta Ardito, A. Armuzzi, G.L. Rapaccini, Luisa Guidi, and Gianluca Andrisani

Subjects
medicine.medical_specialty, Hepatology, business.industry, QUANTIFERON-TB GOLD, Immunology, Gastroenterology, Medicine, Tuberculin, Skin test, business, medicine.disease, Dermatology, Inflammatory bowel disease
Published
2010
Full Text
View/download PDF

20. P.83 LONG TERM EFFICACY OF GRANULOCYTE-MONOCYTE-APHERESIS IN ULCERATIVE COLITIS

Author

P. Lecis, Stefano Passalacqua, Giampaolo Bresci, M. Silla, R. De Franchis, R. Testa, Francesco Costa, D. Valpiani, G. Repaci, A. Saggioro, Mariabeatrice Principi, V. D'Ovidio, Claudio Ricci, Luisa Guidi, Annalisa Aratari, Marco Astegiano, A. Armuzzi, and Maurizio Vecchi

Subjects
medicine.medical_specialty, Hepatology, business.industry, Monocyte, Gastroenterology, Granulocyte, medicine.disease, Ulcerative colitis, medicine.anatomical_structure, Apheresis, Internal medicine, medicine, business
Published
2010
Full Text
View/download PDF

21. ELABORATION DATA SOFTWARE APPLIED TO CEUS FOR QUANTITATIVE EVALUATION OF MICROVASCULAR ACTIVATION AND CORRELATION WITH BIOLOGICAL ACTIVITY IN ILEAL CROHN'S DISEASE

Author

A. Papa, A. De Franco, I. De Vitis, A. Armuzzi, A. Di Veronica, C. Felice, Luisa Guidi, Giammarco Mocci, B. De Pascalis, Manuela Marzo, and I. Roberto

Subjects
medicine.medical_specialty, Pathology, Crohn's disease, Hepatology, business.industry, Gastroenterology, Biological activity, medicine.disease, Correlation, Internal medicine, Medicine, business, Elaboration
Published
2009
Full Text
View/download PDF

22. Homocysteine levels are not related to the extent of bone loss in patients with inflammatory bowel disease

Author

I. Roberto, M. Bonizzi, Silvio Danese, A. Papa, Simona Guglielmo, Alessandro Gasbarrini, Marcello Covino, Luisa Guidi, Giuseppe Fedeli, A. Grillo, G. Gasbarrini, I. De Vitis, and Riccardo Urgesi

Subjects
medicine.medical_specialty, Hepatology, business.industry, Internal medicine, Gastroenterology, medicine, In patient, Homocysteine levels, medicine.disease, business, Inflammatory bowel disease
Published
2006
Full Text
View/download PDF

23. Safety profile of infliximab in inflammatory bowel disease: Single-center experience in 102 patients and 672 infusions

Author

Silvio Danese, Alessandro Gasbarrini, Luisa Guidi, Giuseppe Fedeli, A. Papa, Andrea Lupascu, Domenico Melina, G. Gasbarrini, P. Fedeli, I. De Vitis, I. Roberto, Maria Chiara Mentella, B. De Pascalis, and A. Armuzzi

Subjects
medicine.medical_specialty, Hepatology, business.industry, Gastroenterology, medicine.disease, Single Center, Inflammatory bowel disease, Infliximab, Safety profile, Internal medicine, medicine, business, medicine.drug
Published
2006
Full Text
View/download PDF

24. Push enteroscopy and capsule endoscopy used in diagnosing and staging coeliac disease

Author

G. Gasbarrini, Luisa Guidi, Guido Costamagna, Maria Elena Riccioni, A. Papa, Riccardo Urgesi, V. Piermanni, Giuseppe Fedeli, S. Ennas, and I. De Vitis

Subjects
medicine.medical_specialty, Hepatology, business.industry, Gastroenterology, medicine.disease, Coeliac disease, law.invention, Capsule endoscopy, law, Internal medicine, Push enteroscopy, Medicine, Radiology, business
Published
2006
Full Text
View/download PDF

25. OC.03.4 INFLIXIMAB THREE-DOSE INDUCTION REGIMEN IN ACUTE SEVERE ULCERATIVE COLITIS: EARLY AND LATE OUTCOME AND PREDICTORS OF COLECTOMY

Author

G. Meucci, L. Biancone, Annalisa Aratari, R. Monterubbianesi, A. Orlando, V. F. Annese, A. Armuzzi, Anna Kohn, Sara Onali, Gabriele Riegler, Maria Cappello, Marco Daperno, R. Sostegni, Alessandro Lavagna, Alessandro Gasbarrini, Claudio Papi, Luisa Guidi, and Angelo Viscido

Subjects
medicine.medical_specialty, Hepatology, business.industry, Gastroenterology, medicine.disease, Ulcerative colitis, Peripheral blood mononuclear cell, Infliximab, Nicotine, Regimen, Nicotinic agonist, Internal medicine, medicine, Tumor necrosis factor alpha, Receptor, business, medicine.drug
Abstract

significantly decreased LPS–induced TNFα in PBMC-derived M8 from UC, CD and controls. In contrast, in M8 from biopsies, pretreatment with nicotine selectively decreased LPS-induced intracellular TNFα in cells derived from UC (from 20.85±7.13 to 12.44±7.17 TNFα %fluorescence, p

Published
2014
Full Text
View/download PDF

27. P.06.20 ROLE OF TROUGH LEVELS AND ANTIBODIES TO INFLIXIMAB IN THE EVALUATION OF LOSS OF RESPONSE AND INFUSION REACTIONS TO INFLIXIMAB THERAPY IN INFLAMMATORY BOWEL DISEASE

Author

I. De Vitis, C. Felice, Gianluca Andrisani, B. Tolusso, Luisa Guidi, Manuela Marzo, Elisa Gremese, G.L. Rapaccini, A. Armuzzi, A. Papa, and Daniela Pugliese

Subjects
Infliximab therapy, Antibodies to infliximab, Hepatology, business.industry, Immunology, Gastroenterology, Trough (geology), medicine, medicine.disease, business, Inflammatory bowel disease
Published
2014
Full Text
View/download PDF

28. P.06.21 RETREATMENT WITH INFLIXIMAB IN INFLAMMATORY BOWEL DISEASE: TOLERABILITY AND EFFECTIVENESS OF DIFFERENT RE-INDUCTION REGIMENS

Author

Daniela Pugliese, I. De Vitis, Gianluca Andrisani, Luisa Guidi, A. Papa, G.L. Rapaccini, C. Felice, Manuela Marzo, and A. Armuzzi

Subjects
medicine.medical_specialty, Hepatology, Tolerability, business.industry, Internal medicine, Gastroenterology, Medicine, business, medicine.disease, Inflammatory bowel disease, Infliximab, medicine.drug
Published
2014
Full Text
View/download PDF

29. P.01.1 LONG-TERM OUTCOME IN STEROID-DEPENDENT ULCERATIVE COLITIS TREATED WITH INFLIXIMAB

Author

Daniela Pugliese, A. Armuzzi, Luisa Guidi, C. Felice, G.L. Rapaccini, Silvio Danese, A. Papa, Manuela Marzo, G. Rizzo, G. Fiorino, Gianluca Andrisani, Olga Maria Nardone, and I. De Vitis

Subjects
medicine.medical_specialty, Hepatology, business.industry, Gastroenterology, medicine.disease, Ulcerative colitis, Infliximab, Term (time), Steroid dependency, Internal medicine, medicine, business, medicine.drug
Published
2013
Full Text
View/download PDF

30. P.01.3 LONG TERM SUSTAINABILITY OF MUCOSAL HEALING IN ULCERATIVE COLITIS PATIENTS TREATED WITH INFLIXIMAB

Author

Olga Maria Nardone, Gianluca Andrisani, G.L. Rapaccini, A. Armuzzi, Daniela Pugliese, Manuela Marzo, A. Papa, I. De Vitis, C. Felice, and Luisa Guidi

Subjects
medicine.medical_specialty, Hepatology, business.industry, Gastroenterology, Long term sustainability, medicine.disease, Ulcerative colitis, Infliximab, Internal medicine, Mucosal healing, medicine, business, medicine.drug
Published
2013
Full Text
View/download PDF

31. OC.08.2 ROLE OF FAECAL CALPROTECTIN IN IBD PATIENTS AFTER INDUCTION WITH ANTI-TNF ALPHA AGENTS IN PREDICTING CLINICAL RESPONSE AND MUCOSAL HEALING AT ONE YEAR

Author

C. Felice, Daniela Pugliese, A. Papa, Olga Maria Nardone, A. Armuzzi, Gianluca Andrisani, G.L. Rapaccini, Luisa Guidi, Manuela Marzo, I. De Vitis, and F. Forte

Subjects
medicine.medical_specialty, Hepatology, business.industry, Internal medicine, Mucosal healing, Gastroenterology, medicine, Anti tnf alpha, business, Faecal calprotectin
Published
2013
Full Text
View/download PDF

32. P.02.4 A SINGLE-CENTER COHORT STUDY ON TOLERABILITY OF SHORTENED ONE-HOUR INFLIXIMAB INFUSION TIMES IN IBD PATIENTS

Author

A. Papa, C. Felice, A. Armuzzi, Luisa Guidi, Daniela Pugliese, S. Ennas, Giammarco Mocci, G.L. Rapaccini, Manuela Marzo, Gianluca Andrisani, and I. De Vitis

Subjects
medicine.medical_specialty, Hepatology, Tolerability, business.industry, Internal medicine, Gastroenterology, Medicine, Single Center, business, Infliximab, medicine.drug, Cohort study
Published
2013
Full Text
View/download PDF

33. P.05.3 COMPLEX PERIANAL CROHN'S DISEASE: EFFECTIVENESS OF COMBINED SETON PLACEMENT AND ANTI-TNF ALPHA AGENTS IN MONOTHERAPY OR IN ASSOCIATION WITH IMMUNOSUPPRESSANTS

Author

Gianluca Andrisani, C. Felice, Daniela Pugliese, A. Armuzzi, Carlo Ratto, Angelo Parello, Luisa Guidi, A. Papa, I. De Vitis, Manuela Marzo, and G.L. Rapaccini

Subjects
Perianal Crohn's disease, medicine.medical_specialty, Seton placement, Hepatology, business.industry, Internal medicine, Gastroenterology, Medicine, Anti tnf alpha, business, Surgery
Published
2012
Full Text
View/download PDF

34. P.05.1 QUALITY OF CARE IN INFLAMMATORY BOWEL DISEASE IN ITALY ACCORDING TO IBD CHARACTERISTICS: INITIAL RESULTS FROM SOLUTION TRIAL (AN ONGOING PROSPECTIVE IG-IBD STUDY)

Author

Gaetano Inserra, Stefano Marconi, A. Losco, Michele Comberlato, Silvio Danese, Anna Kohn, Luisa Guidi, P. Lecis, Sandro Ardizzone, Claudio Camillo Cortelezzi, Enrico Colombo, P. Politi, Marco Daperno, R. Sablich, and Aurora Bortoli

Subjects
medicine.medical_specialty, Hepatology, business.industry, Internal medicine, Gastroenterology, medicine, Physical therapy, Quality of care, medicine.disease, business, Inflammatory bowel disease
Published
2012
Full Text
View/download PDF

35. P.16.15 PREVENTION OF POSTOPERATIVE RECURRENCE WITH AZATHIOPRINE OR ANTI-TNF ALPHA IN PATIENTS WITH CROHN'S DISEASE: A PILOT STUDY

Author

I. De Vitis, Daniela Pugliese, Manuela Marzo, G.L. Rapaccini, C. Casale, Luisa Guidi, A. Armuzzi, A. Papa, Gianluca Andrisani, and C. Felice

Subjects
medicine.medical_specialty, Crohn's disease, Hepatology, business.industry, Gastroenterology, Azathioprine, Anti tnf alpha, medicine.disease, Internal medicine, medicine, In patient, business, medicine.drug
Published
2012
Full Text
View/download PDF

36. P.1.218: INFLAMMATORY BOWEL DISEASE (IBD) PATIENTS ON ANTI TNF-ALPHA TREATMENT: RESPONSE TO THE INFLUENZA A/H1N1 VACCINE IN VIVO AND IN VITRO

Author

A. Papa, Daniela Pugliese, Daniela Frasca, A. Armuzzi, Luisa Guidi, I. De Vitis, C. Felice, Giammarco Mocci, Manuela Marzo, G.L. Rapaccini, and Gianluca Andrisani

Subjects
Treatment response, Hepatology, business.industry, In vivo, Immunology, Gastroenterology, Medicine, Influenza a, Anti tnf alpha, business, medicine.disease, Inflammatory bowel disease, In vitro
Published
2011
Full Text
View/download PDF

37. P.1.51: INFLAMMATORY BOWEL DISEASE (IBD) PATIENTS ON ANTI TNF-ALPHA THERAPY: RESPONSE TO THE INFLUENZA A/H1N1 VACCINE

Author

A. Papa, C. Felice, G. Vitale, Luisa Guidi, I. De Vitis, Manuela Marzo, Giammarco Mocci, Daniela Frasca, Gianluca Andrisani, G.L. Rapaccini, A. Armuzzi, and Daniela Pugliese

Subjects
Hepatology, business.industry, Immunology, Gastroenterology, medicine, Influenza a, medicine.disease, business, Inflammatory bowel disease, Anti-TNF-alpha therapy
Published
2011
Full Text
View/download PDF

38. P.1.52: COMPLEX PERIANAL FISTULIZING CROHN'S DISEASE: LONG-TERM EFFICACY OF COMBINED SETON PLACEMENT AND ANTI TNF-ALPHA AGENTS ALONE OR ASSOCIATED WITH IMMUNOSUPPRESSANTS

Author

I. De Vitis, Angelo Parello, G. Vitale, Luisa Guidi, Carlo Ratto, C. Felice, A. Piccioni, Gianluca Andrisani, Daniela Pugliese, Giammarco Mocci, A. Papa, Manuela Marzo, A. Armuzzi, and G.L. Rapaccini

Subjects
Crohn's disease, medicine.medical_specialty, Seton placement, Hepatology, business.industry, Internal medicine, Gastroenterology, Medicine, Anti tnf alpha, business, medicine.disease
Abstract

COMPLEX PERIANAL FISTULIZING CROHN’S DISEASE: LONG-TERM EFFICACY OF COMBINED SETON PLACEMENT AND ANTI TNF-ALPHA AGENTS ALONE OR ASSOCIATEDWITH IMMUNOSUPPRESSANTS A. Armuzzi 1, M. Marzo∗ ,1, G. Mocci 1 , C. Felice1 , D. Pugliese1 , G. Vitale1 , G. Andrisani1, A. Piccioni 1 , A. Papa1, I. De Vitis 1, G. Rapaccini 1 , A. Parello2, C. Ratto2, L. Guidi 1 1U.O.C. Medicina Interna e Gastroenterologia Complesso Integrato Columbus Universita Cattolica Del Sacro Cuore, Roma, Italy; 2U.O.C. Chirurgia Generale Policlinico Gemelli Universita Cattolica Del Sacro Cuore, Roma, Italy

Published
2011
Full Text
View/download PDF

39. OC.07.2: INFLIXIMAB IN STEROID-DEPENDENT ULCERATIVE COLITIS

Author

I. De Vitis, C. Felice, Gianluca Andrisani, Giammarco Mocci, F. De Vincentis, A. Papa, Luisa Guidi, Manuela Marzo, G.L. Rapaccini, Daniela Pugliese, and A. Armuzzi

Subjects
medicine.medical_specialty, Steroid dependency, Hepatology, business.industry, Internal medicine, Gastroenterology, Medicine, business, medicine.disease, Ulcerative colitis, Infliximab, medicine.drug
Published
2011
Full Text
View/download PDF

40. P.92 THE USE OF ADALIMUMAB FOR THE TREATMENT OF CROHN'S DISEASE IN THE CLINICAL SETTING: AN ITALIAN MULTI-CENTER STUDY

Author

Franco Scaldaferri, I. De Vitis, Antonio Tursi, A. Armuzzi, C. Felice, A. Papa, Giammarco Mocci, Alessandro Gasbarrini, Luisa Guidi, Manuela Marzo, Antonio Penna, G. Giorgetti, Giacomo Forti, G.L. Rapaccini, and Gianluca Andrisani

Subjects
Crohn's disease, medicine.medical_specialty, Hepatology, business.industry, Internal medicine, Multi center study, Gastroenterology, Adalimumab, Medicine, business, medicine.disease, medicine.drug
Published
2010
Full Text
View/download PDF

41. P.224 FECAL CALPROTECTIN LEVELS AFTER INDUCTION WITH ANTI-TNF AGENTS IN INFLAMMATORY BOWEL DISEASE CORRELATES WITH THE CLINICAL RESPONSE

Author

C. Felice, A. Armuzzi, I. De Vitis, L. Sparano, G. Vitale, Gianluca Andrisani, A. Papa, Daniela Pugliese, Franca Forni, Manuela Marzo, G.L. Rapaccini, and Luisa Guidi

Subjects
medicine.medical_specialty, Hepatology, business.industry, Internal medicine, Gastroenterology, Medicine, Tumor necrosis factor alpha, Calprotectin, business, medicine.disease, Inflammatory bowel disease, Feces
Published
2010
Full Text
View/download PDF

43. P.96 EFFECT OF ANTI-TNF-ALPHA TREATMENT ON SHORT-TERM POST-OPERATIVE COMPLICATIONS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE

Author

A. Armuzzi, A. Papa, C. Mattana, Daniela Pugliese, Alessandro Verbo, Claudio Coco, I. De Vitis, Luisa Guidi, Gianluca Andrisani, Alberto Manno, G.L. Rapaccini, and G. Rizzo

Subjects
medicine.medical_specialty, Hepatology, business.industry, Internal medicine, Gastroenterology, medicine, In patient, Anti tnf alpha, Post operative, medicine.disease, business, Inflammatory bowel disease
Published
2010
Full Text
View/download PDF

44. P.71 ANTI-TNF THERAPY IN ELDERLY PEOPLE IN IBD: AN ITALIAN MULTICENTRE SURVEY

Author

Marco Daperno, Maria Cappello, Mario Cottone, Livia Biancone, Silvio Danese, Renata D'Incà, Fabrizio Bossa, Luisa Guidi, Claudio Papi, Paolo Gionchetti, A. Orlando, Anna Kohn, A. Armuzzi, Sandro Ardizzone, and Walter Fries

Subjects
medicine.medical_specialty, Hepatology, business.industry, Internal medicine, Gastroenterology, Medicine, Elderly people, Anti-TNF therapy, business
Published
2010
Full Text
View/download PDF

45. THE USE OF ADALIMUMAB IN THE MANAGEMENT OF CROHN'S DISEASE: AN OPEN LABEL SINGLE CENTER STUDY

Author

I. De Vitis, G. Vitale, M. Bonizzi, C. Felice, L. Sparano, Alessandro Gasbarrini, F. De Vincentis, Luisa Guidi, A. Papa, A. Armuzzi, Giammarco Mocci, Manuela Marzo, and Gianluca Andrisani

Subjects
medicine.medical_specialty, Hepatology, business.industry, Internal medicine, Gastroenterology, Adalimumab, medicine, Open label, medicine.disease, Single Center, business, Management of Crohn's disease, medicine.drug
Published
2009
Full Text
View/download PDF

46. COMPUTED TOMOGRAPHY ENTEROGRAPHY IN CROHN'S DISEASE PATIENTS: PREVALENCE OF PENETRATING AND STENOSING DISEASE AND EXTRA-INTESTINAL MANIFESTATIONS

Author

Alessandro Gasbarrini, C. Felice, L. Sparano, Luisa Guidi, G. Vitale, I. De Vitis, M. Bonizzi, A. Papa, Gianluca Andrisani, Giammarco Mocci, A. DeFranco, E. Bock, A. Armuzzi, and Manuela Marzo

Subjects
Crohn's disease, medicine.medical_specialty, Hepatology, business.industry, Gastroenterology, medicine, Disease, Radiology, Computed tomography enterography, medicine.disease, business
Published
2009
Full Text
View/download PDF

47. MUCOSAL HEALING AND RISK OF COLECTOMY IN ULCERATIVE COLITIS PATIENTS: A LONG-TERM FOLLOW-UP STUDY

Author

I. De Vitis, C. Felice, Alessandro Gasbarrini, Manuela Marzo, Luisa Guidi, G. Vitale, A. Armuzzi, M. Bonizzi, Gianluca Andrisani, L. Sparano, A. Papa, and Giammarco Mocci

Subjects
medicine.medical_specialty, Hepatology, Long term follow up, business.industry, medicine.medical_treatment, Gastroenterology, medicine.disease, Ulcerative colitis, Internal medicine, Mucosal healing, medicine, business, Colectomy
Published
2009
Full Text
View/download PDF

48. PA.168 MUCOSAL HEALING IN ULCERATIVE COLITIS PATIENTS IN LONG-TERM TREATMENT WITH INFLIXIMAB

Author

I. Roberto, Antonio Tursi, Giovanni Brandimarte, Walter Elisei, M. Bonizzi, Gianluca Andrisani, S. Ennas, Giammarco Mocci, Carla Felice, Alessandro Gasbarrini, Giuseppe Fedeli, Luisa Guidi, I. De Vitis, A. Papa, and Simona Guglielmo

Subjects
medicine.medical_specialty, Long term treatment, Hepatology, business.industry, Gastroenterology, medicine.disease, Ulcerative colitis, Infliximab, Mucosal healing, Internal medicine, medicine, business, medicine.drug
Published
2008
Full Text
View/download PDF

49. OC3.11.4 SUCCESSFUL INDUCTION OF CLINICAL RESPONSE AND REMISSION WITH CERTOLIZUMAB PEGOL CROHN'S DISEASE PATIENTS: A MULTI-CENTER EXPERIENCE OF COMPASSIONATE USE

Author

Alberto Malesci, A. Manca, F. Mocciaro, Maria Lia Scribano, Michele Comberlato, Marcello Vangeli, Tommaso Stefanelli, R. Pulitano, Silvio Danese, Cosimo Prantera, A. Armuzzi, Mario Cottone, and Luisa Guidi

Subjects
Pediatrics, medicine.medical_specialty, Crohn's disease, Hepatology, business.industry, Gastroenterology, Medicine, Compassionate Use, Center (algebra and category theory), Certolizumab pegol, business, medicine.disease, medicine.drug
Published
2008
Full Text
View/download PDF

50. OC1.02.5 LONG-TERM SCHEDULED THERAPY WITH INFLIXIMAB IN INFLAMMATORY BOWEL DISEASE

Author

I. De Vitis, V. Leso, A. Armuzzi, Alessandro Gasbarrini, Luisa Guidi, I. Roberto, F. Fiore, Giammarco Mocci, Giuseppe Fedeli, B. De Pascalis, A. Papa, F. De Vincentis, Domenico Melina, P. Fedeli, and Manuela Marzo

Subjects
medicine.medical_specialty, Hepatology, business.industry, Internal medicine, Gastroenterology, medicine, business, medicine.disease, Inflammatory bowel disease, Infliximab, Term (time), medicine.drug
Published
2008
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results